Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_provenance.
- NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_assertion description "[GCMB mRNA expression was lower in normal (0.4 +/- 0.1, mean +/- standard error of mean) parathyroid glands as compared to adenoma (3.5 +/- 1.7), hyperplasia (3.2 +/- 1.3 primary hyperparathyroidism [n = 11] and 7.6 +/- 4.8 secondary hyperparathyroidism [n = 5]), and cancer (3.6 +/- 1.3) ( P = .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_provenance.
- NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_assertion evidence source_evidence_literature NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_provenance.
- NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_assertion SIO_000772 15657585 NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_provenance.
- NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_assertion wasDerivedFrom befree-20140225 NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_provenance.
- NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_assertion wasGeneratedBy ECO_0000203 NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_provenance.
- befree-20140225 importedOn "2014-02-25" NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_provenance.